517 related articles for article (PubMed ID: 16285892)
21. The clinical potential of chemokine receptor antagonists.
Ribeiro S; Horuk R
Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
[TBL] [Abstract][Full Text] [Related]
22. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis.
Vielhauer V; Anders HJ; Schlöndorff D
Semin Nephrol; 2007 Jan; 27(1):81-97. PubMed ID: 17336691
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated pathways in chronic inflammatory arthritis.
Gorman CL; Cope AP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):221-38. PubMed ID: 18455681
[TBL] [Abstract][Full Text] [Related]
24. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
26. CCR1 antagonists for the treatment of autoimmune diseases.
Gladue RP; Zwillich SH; Clucas AT; Brown MF
Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
[TBL] [Abstract][Full Text] [Related]
27. Chemokines and chemokine receptors in rheumatoid arthritis.
Szekanecz Z; Kim J; Koch AE
Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptor expression in rat adjuvant-induced arthritis.
Haas CS; Martinez RJ; Attia N; Haines GK; Campbell PL; Koch AE
Arthritis Rheum; 2005 Dec; 52(12):3718-30. PubMed ID: 16320322
[TBL] [Abstract][Full Text] [Related]
29. An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.
Rump L; Mattey DL; Kehoe O; Middleton J
Cytokine; 2017 Sep; 97():133-140. PubMed ID: 28648867
[TBL] [Abstract][Full Text] [Related]
30. Autoantigen signalling through chemokine receptors.
Howard OZ
Curr Opin Rheumatol; 2006 Nov; 18(6):642-6. PubMed ID: 17053513
[TBL] [Abstract][Full Text] [Related]
31. Chemokine receptors: attractive targets for drug discovery.
Godessart N
Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
[TBL] [Abstract][Full Text] [Related]
32. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts.
Gutiérrez-Cañas I; Juarranz Y; Santiago B; Arranz A; Martinez C; Galindo M; Payá M; Gomariz RP; Pablos JL
Rheumatology (Oxford); 2006 May; 45(5):527-32. PubMed ID: 16319097
[TBL] [Abstract][Full Text] [Related]
33. Chemokines and disease.
Gerard C; Rollins BJ
Nat Immunol; 2001 Feb; 2(2):108-15. PubMed ID: 11175802
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic inhibition of leukocyte recruitment in inflammatory diseases.
Szekanecz Z; Koch AE
Curr Opin Pharmacol; 2004 Aug; 4(4):423-8. PubMed ID: 15251139
[TBL] [Abstract][Full Text] [Related]
35. A burgeoning family of biological mediators: chemokines and chemokine receptors.
Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM
Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618
[TBL] [Abstract][Full Text] [Related]
36. The role of resident synovial cells in destructive arthritis.
Ospelt C; Gay S
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):239-52. PubMed ID: 18455682
[TBL] [Abstract][Full Text] [Related]
37. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
[TBL] [Abstract][Full Text] [Related]
38. Drug discovery and chemokine receptor antagonists: eppur si muove!
Terricabras E; Benjamim C; Godessart N
Autoimmun Rev; 2004 Nov; 3(7-8):550-6. PubMed ID: 15546804
[TBL] [Abstract][Full Text] [Related]
39. CC chemokine receptors and chronic inflammation--therapeutic opportunities and pharmacological challenges.
White GE; Iqbal AJ; Greaves DR
Pharmacol Rev; 2013 Jan; 65(1):47-89. PubMed ID: 23300131
[TBL] [Abstract][Full Text] [Related]
40. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
